Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 2 6Phase 3 1Phase 2/3 1

Status

Recruiting 2Completed 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 15Gastrointestinal 6Other hematologic neoplasm 5Thoracic 2Head & Neck 2Classical hematology 2Sarcoma 1Other neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1

Conditions

Colorectal Neoplasms 1290Pancreatic Neoplasms 818Carcinoma, Hepatocellular 782Stomach Neoplasms 753Rectal Neoplasms 563Esophageal Neoplasms 450Colonic Neoplasms 414Esophageal Squamous Cell Carcinoma 275Neoplasm Metastasis 263Cholangiocarcinoma 248Liver Neoplasms 219Neoplasms 199Biliary Tract Neoplasms 179Adenocarcinoma Of Esophagus 139Gastrointestinal Stromal Tumors 108Gallbladder Neoplasms 95Adenocarcinoma 94Gastrointestinal Neoplasms 89Breast Neoplasms 89Carcinoma, Non-Small-Cell Lung 86Bile Duct Neoplasms 69Sarcoma 67Lung Neoplasms 63Ovarian Neoplasms 60Anus Neoplasms 59Melanoma 54Uterine Cervical Neoplasms 51Carcinoma 48Digestive System Neoplasms 45Prostatic Neoplasms 39

Interventions

Drug Therapy 2toripalimab 1tislelizumab 1pembrolizumab 1Tretinoin 1TP protocol 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Oxaliplatin 1Immunotherapy 1Immune Checkpoint Inhibitors 1Fluorouracil 1Esophagectomy 1Chemoradiotherapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Pathologic Complete Response × Gastrointestinal × Clear all
NCT07586813 2026-05-14

N01-A-PICIT-GI

Peking University People's Hospital

Phase 2 Recruiting
220 enrolled
Classical hematologyGastrointestinal

Pathologic Complete Response, Digestive System Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Thrombocytopenia, Colorectal Neoplasms

NCT06647680 2026-03-06

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer(CONTROL-01)

The Affiliated Hospital of Qingdao University

Phase 2 Recruiting
35 enrolled
Gastrointestinal

Pathologic Complete Response, Rectal Neoplasms

NCT07397442 2026-02-11

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

Beijing Friendship Hospital

Phase 2 Not yet recruiting
19 enrolled
Gastrointestinal

Pathologic Complete Response, Rectal Neoplasms

NCT04435197 2024-07-03

PALACE-2

Ruijin Hospital

Phase 2 Completed
143 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response

NCT04006041 2019-12-26

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Sun Yat-sen University

Phase 2 Unknown
44 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response

NCT02353858 2018-02-13

HT01

University Hospital Tuebingen

Phase 2 Completed
78 enrolled
Gastrointestinal

Hyperthermia, Pathologic Complete Response, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡